Microorganism-Derived Molecules as Enzyme Inhibitors to Target Alzheimer’s Diseases Pathways

Alzheimer’s disease (AD) is the most common form of dementia. It increases the risk of other serious diseases and causes a huge impact on individuals, families, and socioeconomics. AD is a complex multifactorial disease, and current pharmacological therapies are largely based on the inhibition of en...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Thi Hanh, Wang, San-Lang, Nguyen, Van Bon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146315/
https://www.ncbi.nlm.nih.gov/pubmed/37111337
http://dx.doi.org/10.3390/ph16040580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146315/
https://www.ncbi.nlm.nih.gov/pubmed/37111337
http://dx.doi.org/10.3390/ph16040580

Ejemplares similares